A double-blind study of dezocine in cancer pain.
A double-blind crossover comparison of intramuscularly administration of 10 mg dezocine (Wy 16225), 10 mg morphine, and placebo in ten patients with cancer pain has shown that a dezocine single dose is superior to placebo in producing relief of moderate to severe pain. No side effects were observed.
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D003516:Cycloparaffins / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D009020:Morphine / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
D000700:Analgesics; D001952:Bridged-Ring Compounds; D003516:Cycloparaffins; D009020:Morphine